[Experts consensus on clinical application of antiphospholipid antibodies detection].
Anti-beta-2 glycoprotein Ⅰ antibody
Anticardiolipin antibody
Antiphospholipid antibody
Antiphospholipid syndrome
Journal
Zhonghua nei ke za zhi
ISSN: 0578-1426
Titre abrégé: Zhonghua Nei Ke Za Zhi
Pays: China
ID NLM: 16210490R
Informations de publication
Date de publication:
01 Jul 2019
01 Jul 2019
Historique:
entrez:
4
7
2019
pubmed:
5
7
2019
medline:
12
7
2019
Statut:
ppublish
Résumé
Antiphospholipid antibodies (aPLs) are a group of autoantibodies that target phospholipids and/or phospholipid-binding proteins. aPLs are important serum markers of anti phospholipid syndrome and are also risk factors for thrombosis and pathological pregnancy. Standardization of aPLs detection is critical to its clinical application. 抗磷脂抗体（aPLs）是一组以磷脂和/或磷脂结合蛋白为靶抗原的自身抗体总称。aPLs是抗磷脂综合征的重要血清标志物，亦是血栓形成和病理妊娠的危险因素。aPLs检测的标准化对其临床应用至关重要。.
Autres résumés
Type: Publisher
(chi)
抗磷脂抗体（aPLs）是一组以磷脂和/或磷脂结合蛋白为靶抗原的自身抗体总称。aPLs是抗磷脂综合征的重要血清标志物，亦是血栓形成和病理妊娠的危险因素。aPLs检测的标准化对其临床应用至关重要。.
Identifiants
pubmed: 31269565
doi: 10.3760/cma.j.issn.0578-1426.2019.07.003
doi:
Substances chimiques
Antibodies, Anticardiolipin
0
Antibodies, Antiphospholipid
0
Biomarkers
0
beta 2-Glycoprotein I
0
Types de publication
Journal Article
Langues
chi
Sous-ensembles de citation
IM
Pagination
496-500Subventions
Organisme : Chinese National Key Research and Development Program
ID : 2017YFC0907600
Organisme : National Natural Science Foundation of China
ID : 81771780
Organisme : Chinese Academy of Medical Sciences Initiative for Innovative Medicine
ID : 2017-I2M-3-001